ERBİLGİN, Y. Et Al. 2013. Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 55.th ASH meeting .

ERBİLGİN, Y., Eşkazan, E., HATIRNAZ NG, Ö., Salihoğlu, A., ELVERDİ, T., Fırtına, S., ... Çatal Tatonyan, S.(2013). Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance . 55.th ASH meeting

ERBİLGİN, YÜCEL Et Al. "Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance," 55.th ASH meeting, 2013

ERBİLGİN, YÜCEL Et Al. "Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance." 55.th ASH meeting , 2013

ERBİLGİN, Y. Et Al. (2013) . "Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance." 55.th ASH meeting .

@conferencepaper{conferencepaper, author={YÜCEL ERBİLGİN Et Al. }, title={Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance}, congress name={55.th ASH meeting}, city={}, country={}, year={2013}}